Products for Research Use Only

PF-06409577

CAT: 0013-GTR19163160-01Size: 1 gDry Ice: NoHazardous: No
Product image 1
1 / 1
CAT#:0013-GTR19163160-01Size:1 g
Selected
24/48H Stock Items & 2 to 6 Weeks non Stock Items.
Quick Request Actions
Description
PF-06409577 (PF06409577, PF 6409577) is a potent, selective AMPK β1-containing isoforms activator with TR-FRET EC50 of 7.0 and 6.8 nM for α1β1γ1 and α2β1γ1, respectively; displays no activity for α1β2γ1/α2β2γ1/α2β2γ3 with EC50 >40 uM; elevates the phosphorylation of AMPK in the kidney, without impacting blood glucose levels, and reduces the progression of proteinuria in rat model of diabetic nephropathy.Diabetes Phase 1 Discontinued (In Vitro) :PF-06409577 possesses similar potency toward the human and rat α1��1γ1 isoforms. In broad panel screening against other receptors, channels, PDEs and kinases, PF-06409577 exhibits minimal off-target pharmacology. PF-06409577 shows no detectable inhibition of hERG in a patch-clamp assay (100 μM) and is not an inhibitor (IC50>100 μM) of the microsomal activities of major human cytochrome P450 isoforms. (In Vivo) :PF-06409577 demonstrates moderate plasma clearance in rats, dogs, and monkeys, and is well distributed with steady state distribution volume. Following oral administration of crystalline PF-06409577 in 0.5% methylcellulose suspension, PF-06409577 is rapidly absorbed in rats, dogs, and monkeys. The corresponding oral bioavailability values in rats, dogs, and monkeys, are 15%, 100%, and 59%, respectively. Dose responsive increases in pAMPK relative to total AMPK (tAMPK) in whole kidney tissue are observed with a maximal 3.8-fold response at 300 mg/kg PF-06409577 treatment. Oral administration of PF-06409577 (10, 30, and 100 mg/kg QD) results in dose-dependent reductions in proteinuria in the obese ZSF1 animals, with greater than 2-fold reduction in 24-hour urinary albumin loss compared to vehicle control after 60 days of treatment.
CAS Number
1467057-23-3
Product Name Alternative
PF 06409577 | PF06409577 | PF 6409577
Purity
>98% (HPLC)
Solubility
DMSO: 34.2 mg/mL (100 mM) ; Ethanol: 6.8 mg/mL (20 mM) (< 1 mg/ml refers to the product slightly soluble or insoluble)
Smiles
O=C (C1=CNC2=C1C=C (C3=CC=C (C4 (O) CCC4) C=C3) C (Cl) =C2) O
Molecular Formula
C19H16ClNO3
Molecular Weight
341.79
Storage Conditions
Storage temperature: -20°C. Stability: ≥ 2 years
Notes
For research use only.
Other Product Names
6-Chloro-5-[4- (1- hydroxycyclobutyl) phenyl]-1H-indole-3-carboxylic acid